Cover Image
市場調查報告書

全球兒童用藥物及疫苗市場

Pediatric Drugs and Vaccines

出版商 Global Industry Analysts, Inc. 商品編碼 243089
出版日期 內容資訊 英文 419 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球兒童用藥物及疫苗市場 Pediatric Drugs and Vaccines
出版日期: 2014年09月01日 內容資訊: 英文 419 Pages
簡介

本報告提供全球兒童用藥物及疫苗市場相關調查,為您彙整美國,加拿大,日本,歐洲,亞太地區,南美等地區別分析,今後的市場預測,及打入市場的主要企業簡介等資料。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • 小兒科
    • 兒童用藥物市場
    • 近幾年的藥物認證
    • 美國及歐洲:主要市場
    • 發展中國家市場迅速發展
    • 抗感染藥,抗過敏/呼吸系統藥物
    • 兒童用疫苗:最快發展的市場區隔
    • 處方荷爾蒙劑促進兒童用藥物的成長
    • 臨床實驗和開發平台分析
  • 市場趨勢與課題
    • 肥胖相關症狀上兒童用藥物的可能性
    • 達到第三階段的兒童用心血管疾病藥物
    • 資金不足阻礙了兒童用藥物臨床實驗的開發 其他
  • 法律制度
    • 缺乏兒童用藥物開發的投注力
    • 各種法規當局的指南
    • 美國FDA
    • 兒童用藥物實驗的法律規章發展 其他
  • 兒童用疫苗市場
    • 疫苗接種
    • 主要的兒童用疫苗製造商市場佔有率
    • 開發平台的兒童用疫苗
    • 兒童用疫苗的種類 其他
  • 小兒科疾病:概要,統計及治療
    • 感染疾病
    • 流感
    • 尿道感染
    • 腮腺炎感冒
    • 念珠菌感染
    • 蘋果病 其他
  • 已通過核準的兒童用藥物清單
  • 產品引進/技術創新
  • 近幾年的產業活動
  • 主要企業
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
  • 亞太地區各國
    • 中國
    • 印度
  • 南美
  • 其他
  • 標示變更為兒童用的FDA已認証藥物清單
  • 透過FDA取得兒童用壟斷權的藥物清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6503

This report analyzes the worldwide markets for Pediatric Drugs and Vaccines in US$ Million by the following Therapeutic Class: Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs, and Other Pediatric Drugs. The market for 'Pediatric Vaccines' in this report is analyzed by the following Type: Combinations, Hepatitis, MMR, Varicella, Poliovirus, Pneumococcal, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 120 companies including many key and niche players such as -

Actelion Pharmaceuticals Ltd.
Abbott Laboratories
Allergan, Inc.
Amgen, Inc.
AstraZeneca Plc

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Pediatrics: A Highly Underserved and Undervalued Group
    • Table 1: Global Birth Rate Statistics (2012) by Crude Birth Rates per 1000 Population for Key Countries
  • Pediatric Drugs Market - An Abode of Opportunities
  • Recent Pediatric Drug Approvals: 2011-2014
  • Pediatric Exclusivity Drives Manufacturers' Interest
  • The United States and Europe: Major Markets for Pediatric Drugs
  • Developing Markets to Witness Faster Growth
    • Table 2: Per-Capita Healthcare Expenditure in Select Regions (2013) (includes corresponding Graph/Chart)
    • Table 3: Top 20 Countries with the Highest Healthcare Spending as a Percentage of GDP (2012) (includes corresponding Graph/Chart)
    • Table 4: Developing Regions Lead Children Population Globally (includes corresponding Graph/Chart)
    • Table 5: Asia-Pacific Proportion of Children (0-15 Years Age Group) by Select Country: 2013 (includes corresponding Graph/Chart)
    • Table 6: Latin American Proportion of Children (0-15 Years Age Group) by Country: 2013 (includes corresponding Graph/Chart)
    • Table 7: European Proportion of Children (0-15 Years Age Group) by Select Country: 2013 (includes corresponding Graph/Chart)
    • Table 8: The Middle Eastern Proportion of Children (0-15 Years Age Group) by Country: 2013 (includes corresponding Graph/Chart)
  • Anti-Infectives, and Anti-Allergy/RespiratoryDrugs: Largest Selling Drug Classes
  • Pediatric Vaccines: The Fastest Growing Market Segment
    • Table 9: Global Prevnar 13 Vaccine Sales by Region: 2013 (includes corresponding Graph/Chart)
  • Prescription Hormone Drugs to Drive Pediatric Drugs Growth
    • Table 10: Global Pediatric Drugs Market by Therapeutic Class: Segments Ranked by Growth (includes corresponding Graph/Chart)
  • Clinical Studies and Pipeline Analysis
    • Table 11: Global On-Going Pediatric Drugs Clinical Studies by Country/Region (includes corresponding Graph/Chart)
    • Table 12: Global Pediatric Drugs Pipeline by Select Therapeutic Area (2012): Number of Drugs Under Development for Cancer, Genetic Diseases, Infectious Diseases, Neurological Diseases, Respiratory Diseases, Skin Disorders, Psychiatric Diseases, Cardiovascular Ailments, Diabetes, GI Diseases, Eye Diseases, Arthritis/Musculoskeletal, and Others (includes corresponding Graph/Chart)

2. MARKET TRENDS AND ISSUES

  • Potential for Pediatric Drugs Against Obesity-related Conditions
    • Table 13: Top 10 Countries with the Highest Proportion of Overweight Children (includes corresponding Graph/Chart)
  • Recent Phase III Completed Pediatric Cardiovascular Drugs
  • Lack of Adequate Funding Hinders Pediatric Drug Trials
  • Modeling & Simulation - A Powerful Tool for Pediatric Clinical Study Sponsors
  • Pharmacometrics Approaches Gain Traction Among US and EU Researchers
  • Challenges Associated with Adoption of Pharmacometric Approach
  • Guidelines for Conducting Ethically Correct Clinical Trials
  • Controversial Off-Label Drug Usage in the Pediatric Healthcare Market
  • The US Leads the Pediatric ADHD Drugs Market
  • Non-Stimulant ADHD Drugs Gaining Market
    • Table 14: Global ADHD Non-Stimulant Drugs Market by Type (2014): Percentage Market Share Breakdown of Prescription Sales for Kapvay, Intuniv, & Strattera (includes corresponding Graph/Chart)
  • Orphan Drugs for Pediatric Use Gain Popularity
  • Pediatric Orphan Drugs in Pipeline as of Year 2013
  • Need for Higher Focus on Fixed-Dose Combination for Pediatric HIV Infections
  • Select Pediatric Antiretroviral Drugs in Pipeline (2014)
  • Pediatric Growth Hormone Drug Market Offers Potential II-24 Efforts to Ease Drug Use in Children Continues

3. REGULATORY ENVIRONMENT

  • Historical Lack of Focus on Pediatric Drug Development
  • Pediatric Guidelines by Different Regulatory Bodies
  • US Food and Drug Administration (USFDA)
  • Evolution of Regulations for Pediatric Drug Testing
  • New Regulations Incentivize Clinical Trials with Pediatric Subjects
  • PREA and BPCA - A Boon for Pharma Companies
  • European Medicines Agency (EMA)
  • EMA Rolls out Regulations for Pediatric Clinical Studies
  • Malaysian Pediatric Association (MPA)
  • Harmonization of Disparate Regional Regulations & Processes - the Next Step
  • International Conference on Harmonisation (ICH) Guidelines for Pediatric Formulations

4. PEDIATRIC VACCINES MARKET

    • Table 15: Number of Reported Cases for Vaccine-Preventable Diseases Globally: 2009-2013
  • Immunization Coverage
  • Immunization Coverage: 2013, 2012, and 2011
    • Table 16: Routine Immunization Coverage (2013): Percentage of Live Births/New Borns/Infants/ Children Vaccinated by Select Region
    • Table 17: Routine Immunization Coverage (2012): Percentage of Live Births/New Borns/Infants/ Children Vaccinated by Select Region
    • Table 18: Routine Immunization Coverage (2011): Percentage of Live Births/New Borns/Infants/ Children Vaccinated by Select Region
  • Market Share of Leading Pediatric Vaccine Manufacturers
    • Table 19: Global Pediatric Vaccines Market by Leading Players (2013): Percentage Market Share Breakdown of Dollar Sales for GlaxoSmithKline, Novartis, Sanofi-Pasteur, Merck, and Others (includes corresponding Graph/Chart)
  • Pediatric Vaccines in Pipeline
  • Pediatric Vaccine Types
  • Hemophilus Influenza Type B Vaccine
    • Available Hib and Combination Vaccines
  • Diphtheria/Tetanus/Pertussis Vaccines (DTaP Vaccines)
    • Available DTaP and Combination Vaccines
    • Table 20: Global DTP3 Immunization Coverage: 2003-2013 (includes corresponding Graph/Chart)
    • Table 21: Developing Countries With % of Districts Achieving at Least 80% DTP3 coverage, 2013 (includes corresponding Graph/Chart)
  • Hepatitis A Vaccine
    • Available Hepatitis A and Combination Vaccines
  • Hepatitis B Vaccine
  • Hepatitis B Epidemiology
    • Available Hepatitis B and Combination Vaccines
  • Measles/Mumps/Rubella (MMR) Vaccines
    • Available MMR and Combination Vaccines
  • Rotavirus Vaccines
    • Available Rotavirus Vaccine
  • Polio Vaccines
    • Available Polio and Combination Vaccines
  • Varicella Vaccine
    • Available Varicella Vaccines
  • Pneumococcal Disease Vaccines
    • PCV 13 Replaces PCV 7
      • Available Pneumococcal Conjugate Vaccine
  • Meningococcal Vaccines
    • Available Meningococcal Polysaccharide and Combination vaccine
  • Combination Vaccines
  • Select Market Trends and Issues
  • Innovations Drive the Infectious Disease Market
  • Hepatitis B Combination Vaccines to Propel Market Growth
    • Table 22: Number of Countries Having Introduced HepB Vaccine: 2003-2013 (includes corresponding Graph/Chart)
    • Table 23: Global Infant HepB3 Coverage: 2003-2013 (includes corresponding Graph/Chart)
  • Conjugated and Protein-based Vaccines to Take over Polysaccharide Vaccines for Infectious Diseases
    • List of Infectious Disease Vaccines in the R&D Pipeline (2014)
  • Rising Women Workforce Propels Pediatric Vaccines Growth
    • Table 24: Female Employment-to-Population Ratio (%): 2002, 2007 & 2012 (includes corresponding Graph/Chart)

5. PEDIATRIC DISEASES - OVERVIEW, STATISTICS & TREATMENT

  • Infective Diseases
  • Recent Phase III Completed Pediatric Drugs for Infectious Diseases
  • Influenza
    • Treatment
  • Urinary Tract Infection (UTI)
    • Prevalence
    • Treatment
  • Mumps
    • Complications Related to Mumps
    • Prevention of Mumps in children
    • Incidence
  • Candidiasis
  • Fifth Disease
  • Molluscum Contagiosum
  • Roseola
  • Tetanus
  • Whooping Cough
  • Allergy and Respiratory Diseases
  • Recent Phase III Completed Pediatric Drugs for Respiratory Disorders
  • Prevalence Statistics
    • The US
    • Other Countries
  • Diphtheria
    • Incidence and Mortality Statistics
  • Upper Respiratory Infection (Common Cold)
    • Diagnosis & Treatment
  • Measles
    • Statistics
  • Asthma
    • Prevalence
  • Central Nervous System Disorders
  • Recent Phase III Completed Pediatric Drugs for Neurological/Psychatric Disorders
  • Mental Disorders
    • Prevalence
  • Attention Deficit Hyperactivity Disorder
    • Prevalence
  • Depression
    • Prevalence
  • Epilepsy
    • Epilepsy Treatment
    • Incidence and Prevalence of Epilepsy in the US
  • Hormonal Disorders
  • Diabetes Mellitus
    • Recent Phase III Completed Pediatric Drugs for Diabetes
  • Hypothyroidism
    • Hypothyroidism in Infants and Children
      • Symptoms and Diagnosis
      • Treatment of Hypothyroidism in Children
  • Precocious Puberty
    • Symptoms and Signs
      • Signs of Early Puberty in Girls and Boys
    • Treatment
  • Hypopituitarism
    • Treatment
  • Lymphocytic Thyroiditis
    • Symptoms
    • Treatment
  • Other Diseases
  • Cardiovascular Diseases
    • Hypertension
      • Causes of Hypertension in Children
      • Symptoms of High Blood Pressure
      • Treatment
  • Cancers
    • Brain Tumors
      • Prevalence
    • Leukemia
      • Prevalence
    • Lymphomas
      • Prevalence
    • Retinoblastoma
      • Prevalence
    • Ewing's Sarcoma
      • Symptoms and Treatment
      • Prevalence
    • Wilms' Tumor
      • Stages and Treatment
      • Prevalence & Incidence
    • Children's Rhabdomyosarcoma
      • Symptoms and Signs
      • Treatment
      • Statistics
    • Neuroblastoma
      • Symptoms
      • Treatment
    • Osteogenic Sarcoma
      • Prevalence
      • Symptoms and Treatment
  • Gastrointestinal Disorders
  • Recent Phase III Completed Pediatric Drugs for Gastrointestinal Disorders
  • Diarrhea
  • Inflammatory Bowel Disease (IBD)
    • Symptoms
    • Treatment
  • Irritable Bowel Syndrome (IBS)
    • Causes & Symptoms
    • Treatment
  • Pain
    • Pain Control Medicines for Children
    • Statistics
      • Pain Statistics Among the American Children, General Population, and Other Adults
  • Malaria
  • Anemia
    • Treatment for Anemia in Children
      • Recent Phase III Completed Pediatric Drugs for Genetic Disorders

6. LIST OF SELECT FDA APPROVED PEDIATRIC DRUGS

7. PRODUCT INTRODUCTIONS/INNOVATIONS

  • Sanofi Pasteur Receives prequalification status for Shan5™
  • Immune ResponseReceives US FDA Orphan Drug Status for Remune Vaccine
  • Merck's ISEMTRESS Receives FDA Approval
  • Valneva Receives FDA Market Exclusivity for IXIARO®
  • Merck Receives FDA Grant for Production of Live Virus Material
  • Flu Vaccine Receives FDA Approval
  • Sanofi Pasteur Receives EU Approval for Hexyon/Hexacima Pediatric Vaccine
  • Novartis Receives FDA Approval for Menveo
  • ROTAVAC Receives Approval
  • MenHibrix Receives Approval
  • GSK Receives EU Approval for Nimenrix
  • Sanofi Pasteur to Launch New Vaccines
  • FDA Approves Omalizumab as Safe Drug for Children
  • ACETO Corporation to unveil generic Cleocin Pediatric Antibiotic
  • GlaxoSmithKline Receives Approval for MenHibrix
  • CHMP Grants Approval for Glaxo's Nimenrix
  • Sanofi Receives EMA Approval for Hexaxim

8. RECENT INDUSTRY ACTIVITY

  • GSK Forms Joint Venture with Biological E to Develop Pediatric Vaccine
  • Novartis Discontinues JV with Panacea Biotec
  • GSK Inks a Joint Venture with Biological E
  • Nuron Biotech Inks Licensing agreement with Mitsubishi Tanabe
  • DNDi Collaborates with Cipla For Development of 4-in-1 Pediatric Drug
  • Merz Acquires CUVPOSA Oral Solution

9. FOCUS ON SELECT GLOBAL PLAYERS

  • Actelion Pharmaceuticals Ltd (Switzerland)
  • Abbott Laboratories (US)
  • Allergan, Inc. (US)
  • Amgen, Inc. (US)
  • AstraZeneca Plc. (UK)
  • Boehringer Ingelheim GmbH (Germany)
  • Bristol-Myers Squibb Company (US)
  • Crucell N.V. (The Netherlands)
  • Eli Lilly and Company (US)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Genentech, Inc. (US)
  • GlaxoSmithKline plc. (UK)
  • InfaCare, Inc. (USA)
  • Merck & Co., Inc. (US)
  • Merck Serono (Switzerland)
  • Novartis AG (Switzerland)
  • Novo Nordisk A/S (Denmark)
  • Pfizer, Inc. (US)
  • Sanofi S.A (formerly Sanofi-Aventis) (France)
  • Shionogi Inc. (US)
  • Shire Pharmaceuticals Group Plc (UK)

10. GLOBAL MARKET PERSPECTIVE

    • Table 25: World Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 26: World Historic Review for Pediatric Drugs and Vaccines by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 27: World 15-Year Perspective for Pediatric Drugs and Vaccines by Geographic Region - Percentage Share Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 28: World Recent Past, Current & Future Analysis for Pediatric Vaccines by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 29: World Historic Review for Pediatric Vaccines by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 30: World 15-Year Perspective for Pediatric Vaccines by Geographic Region - Percentage Share Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 31: World Recent Past, Current & Future Analysis for Pediatric Hormones by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 32: World Historic Review for Pediatric Hormones by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 33: World 15-Year Perspective for Pediatric Hormones by Geographic Region - Percentage Share Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 34: World Recent Past, Current & Future Analysis for Pediatric Allergy & Respiratory Drugs by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 35: World Historic Review for Pediatric Allergy & Respiratory Drugs by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 36: World 15-Year Perspective for Pediatric Allergy & Respiratory Drugs by Geographic Region - Percentage Share Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 37: World Recent Past, Current & Future Analysis for Pediatric Anti-infective Drugs by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 38: World Historic Review for Pediatric Anti-infective Drugs by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 39: World 15-Year Perspective for Pediatric Anti-infective Drugs by Geographic Region - Percentage Share Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 40: World Recent Past, Current & Future Analysis for Pediatric CNS Drugs by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 41: World Historic Review for Pediatric CNS Drugs by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 42: World 15-Year Perspective for Pediatric CNS Drugs by Geographic Region - Percentage Share Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 43: World Recent Past, Current & Future Analysis for Other Pediatric Drugs by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 44: World Historic Review for Other Pediatric Drugs by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 45: World 15-Year Perspective for Other Pediatric Drugs by Geographic Region - Percentage Share Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 46: World Recent Past, Current & Future Analysis for Pediatric Vaccines by Type - Combinations, Hepatitis, MMR, Varicella, Poliovirus, Pneumococcal, and Other Markets Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 47: World 15-Year Perspective for Pediatric Vaccines by Type - Percentage Share Breakdown of Dollar Sales for Combinations, Hepatitis, MMR, Varicella, Poliovirus, Pneumococcal, and Other Markets for Years 2014 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Major Diseases Afflicting Children in the US
    • Pediatric Drugs Market in the US
    • Market Trends and Issues
      • Pediatric Drugs Witness Supply Shortages
      • Measures Taken to Reduce Supply Shortages
      • Low Enthusiasm for Drug Development Research
      • Lack of New Drugs in Pipeline
      • Manufacturing Challenges
      • New Pediatric Indications for Existing Drugs
      • Pediatric ADHD Drugs Continue to Witness High Prescription Rate
    • Table 48: The US ADHD Market by Segment (2013): Percentage Share of Total Prescriptions for Adult ADHD and Pediatric ADHD (includes corresponding Graph/Chart)
      • Rising Incidence of Diabetes Mellitus in North America
    • Table 49: North America Incidence of Type 1 Diabetes in Children (2012) (includes corresponding Graph/Chart)
      • FDA Approved Antidepressants in Pediatric Patients
      • FDA-Approved Antidepressant Medication by Indication and Age-Group
      • Use of Antidepressant Medications in Pediatric Patients: Treatment Guidelines
      • Pediatric Antidepressant Drugs and Black Box Warnings
      • List of Drugs Mandated by FDA to Carry Black Box Warning on Suicidal Ideation in Adolescents and Children
      • OTC Drugs Market to Maintain Growth Momentum
    • Regulatory Environment
      • Evolution of Regulations for Pediatric Drug Testing
      • New Regulations Incentivize Clinical Trials with Pediatric Subjects
      • PREA and BPCA - A Boon for Pharma Companies
    • Pediatric Vaccines Market Witnesses Rapid Growth
      • Anti-Vaccination Trend Restricting the Market
      • Improved Pricing Scenario for Pediatric Vaccines
      • Affordable Care Act Favoring the US Pediatric Drugs Market
      • Child Population & Birth Rates
    • Table 50: Child Birth in the US: Breakdown of Number of Births per 1,000 Population for the Years 2003 through 2012 (includes corresponding Graph/Chart)
      • Opportunity Indicator
    • Table 51: Number of reported cases for Vaccine-Preventable Diseases in American Regions
    • Table 52: Routine Immunization Coverage in the US (2011-2013): Percentage of Live Births/ New Borns/Infants/Children Vaccinated
    • Immunization Program
      • Recommended Immunization Schedule for Persons Aged 0 through 18 Years - United States, 2014
      • Catch-Up Immunization Schedule for Persons Aged 4 Months through 18 Years Who Start Late or Who are More than 1 Month Behind -United States, 2014
    • Product Launches/Approvals
    • Strategic Corporate Developments
    • Focus on Select Major Players
  • B. Market Analytics
    • Table 53: The US Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 54: The US Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 55: The US 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Share Breakdown of Dollar Sales for Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Opportunity Indicator
    • Table 56: Canadian Routine Immunization Coverage (2011-2013): Percentage of Live Births/New Borns/Infants/Children Vaccinated
  • B. Market Analytics
    • Table 57: Canadian Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 58: Canadian Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 59: Canadian 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Share Breakdown of Dollar Sales for Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Opportunity Indicator
    • Table 60: Japanese Routine Immunization Coverage (2011-2013): Percentage of Live Births/ New Borns/Infants/Children Vaccinated
  • B. Market Analytics
    • Table 61: Japanese Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 62: Japanese Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 63: Japanese 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Share Breakdown of Dollar Sales for Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Table 64: Proportion of Children in the 0-15 Years Age Group by Country in Europe (2013) (includes corresponding Graph/Chart)
    • EMA Rolls out Regulations for Pediatric Clinical Studies
    • Market Challenges
      • Cost Considerations
      • Child-Friendly Drug Forms
    • Product Approval
  • B. Market Analytics
    • Table 65: European Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of European Markets Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 66: European Historic Review for Pediatric Drugs and Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of European Markets Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 67: European 15-Year Perspective for Pediatric Drugs and Vaccines by Geographic Region - Percentage Share Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of European Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 68: European Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 69: European Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 70: European 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Share Breakdown of Dollar Sales for Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Opportunity Indicator
    • Table 71: French Routine Immunization Coverage (2011-2013): Percentage of Live Births/New Borns/Infants/Children Vaccinated
    • Product Launches
    • Focus on Select Major Player
  • B. Market Analytics
    • Table 72: French Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 73: French Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 74: French 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Share Breakdown of Dollar Sales for Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Opportunity Indicator
    • Table 75: German Routine Immunization Coverage (2011-2013): Percentage of Live Births/New Borns/Infants/Children Vaccinated
    • Select Major Player
  • B. Market Analytics
    • Table 76: German Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 77: German Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 78: German 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Share Breakdown of Dollar Sales for Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Opportunity Indicator
    • Table 79: Italian Routine Immunization Coverage (2011-2013): Percentage of Live Births/New Borns/Infants/Children Vaccinated
  • B. Market Analytics
    • Table 80: Italian Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 81: Italian Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 82: Italian 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Share Breakdown of Dollar Sales for Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Opportunity Indicator
    • Table 83: The UK Routine Immunization Coverage (2011-2013): Percentage Of Live Births/New Borns/Infants/Children Vaccinated
    • Focus on Select Major Players
  • B. Market Analytics
    • Table 84: The UK Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 85: The UK Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 86: The UK 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Share Breakdown of Dollar Sales for Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Opportunity Indicator
    • Table 87: Spanish Routine Immunization Coverage (2011-2013): Percentage of Live Births/New Borns/Infants/Children Vaccinated
  • B. Market Analytics
    • Table 88: Spanish Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 89: Spanish Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 90: Spanish 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Share Breakdown of Dollar Sales for Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4f. RUSSIA

  • A. Market Analysis
    • Opportunity Indicator
    • Table 91: Russian Routine Immunization Coverage (2011-2013): Percentage of Live Births/New Borns/Infants/Children Vaccinated
  • B. Market Analytics
    • Table 92: Russian Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 93: Russian Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 94: Russian 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Share Breakdown of Dollar Sales for Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Opportunity Indicator
    • Table 95: Number of reported cases for Vaccine-Preventable Diseases in Eastern European Region
    • Focus on Select Major Players
  • B. Market Analytics
    • Table 96: Rest of Europe Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 97: Rest of Europe Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 98: Rest of Europe 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Share Breakdown of Dollar Sales for Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Table 99: Proportion of Children in the 0-15 Years Age Group by Country in Asia-Pacific (2013) (includes corresponding Graph/Chart)
    • Burgeoning Middle Class Population in Asia Bodes Well for Market Growth
    • Table 100: World Middle Class Population (2012 & 2030): Percentage Share Breakdown by Region - North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (includes corresponding Graph/Chart)
    • Vaccines Market in Asia-Pacific
    • Opportunity Indicator
    • Table 101: Number of reported Cases for Vaccine-Preventable Diseases in South-East Asia
    • Table 102: Number of reported cases for Vaccine-Preventable Diseases in West-Pacific Region
  • B. Market Analytics
    • Table 103: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 104: Asia-Pacific Historic Review for Pediatric Drugs and Vaccines by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 105: Asia-Pacific 15-Year Perspective for Pediatric Drugs and Vaccines by Geographic Region - Percentage Share Breakdown of Dollar Sales for China, India, and Rest of Asia-Pacific Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 106: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 107: Asia-Pacific Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 108: Asia-Pacific 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Share Breakdown of Dollar Sales for Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • Chinese Market Outlook
    • Opportunity Indicator
    • Table 109: Chinese Routine Immunization Coverage (2011-2013): Percentage of Live Births/New Borns/Infants/Children Vaccinated
    • Growing Pediatric Market in China
    • Table 110: Chinese Population (2001-2013): Percentage Breakdown of Population by Age Group (includes corresponding Graph/Chart)
    • China Sets Eyes on Supporting Pediatric Drugs Market
    • Expediting R&D and Drug Review Process
    • Strengthening Policies Related to Pediatric Drug Production and Supply
    • Enhancing Clinical Usage of Pediatric Drugs
    • Implementation of Safety and Quality Control Measures
    • Harmonizing Chinese and Western Drugs
    • Increasing Public Awareness
  • B. Market Analytics
    • Table 111: Chinese Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 112: Chinese Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 113: Chinese 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Share Breakdown of Dollar Sales for Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5b. INDIA

  • A. Market Analysis
    • Opportunity Indicator
    • Table 114: Indian Routine Immunization Coverage (2011-2013): Percentage of Live Births/New Borns/Infants/Children Vaccinated
    • Pediatric Drug Development in India
    • Strategic Corporate Developments
    • Product Approval
  • B. Market Analytics
    • Table 115: Indian Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 116: Indian Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 117: Indian 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Share Breakdown of Dollar Sales for Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Opportunity Indicator
    • Table 118: Routine Immunization Coverage in Republic of Korea (2011-2013): Percentage of Live Births/New Borns/Infants/Children Vaccinated
  • B. Market Analytics
    • Table 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 120: Rest of Asia-Pacific Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 121: Rest of Asia-Pacific 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Share Breakdown of Dollar Sales for Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • A. Market Analysis
    • Table 122: Proportion of Children in the 0-15 Years Age Group by Country in Latin America (2013) (includes corresponding Graph/Chart)
    • Opportunity Indicator
    • Table 123: Brazilian Routine Immunization Coverage (2011-2013): Percentage of Live Births/New Borns/Infants/Children Vaccinated
  • B. Market Analytics
    • Table 124: Latin American Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 125: Latin American Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 126: Latin American 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Share Breakdown of Dollar Sales for Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Opportunity Indicator
    • Table 127: Proportion of Children in the 0-15 Years Age Group by Country in the Middle East (2013) (includes corresponding Graph/Chart)
    • Table 128: Saudi Arabian Population (2001-2013): Percentage Breakdown of Population by Age Group (includes corresponding Graph/Chart)
    • Table 129: Number of Reported Cases for Vaccine-Preventable Diseases in Africa: 2009-2013
    • Table 130: South African Routine Immunization Coverage (2011-2013): Percentage of Live Births/New Borns/Infants/Children Vaccinated
    • Table 131: Central African Routine Immunization Coverage (2011-2013): Percentage of Live Births/New Borns/Infants/Children Vaccinated
  • B. Market Analytics
    • Table 132: Rest of World Recent Past, Current & Future Analysis for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 133: Rest of World Historic Review for Pediatric Drugs and Vaccines by Therapeutic Class - Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market Independently Analyzed with Annual Sales in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 134: Rest of World 15-Year Perspective for Pediatric Drugs and Vaccines by Therapeutic Class - Percentage Share Breakdown of Dollar Sales for Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs and Other Pediatric Drugs Market for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

8. APPENDIX 1: LIST OF ALREADY APPROVED FDA DRUM8GS FOR WHICH LABELING CHANGES WERE MADE TO INCLUDE PEDIATRIC INDICATIONS - 2014 & 2013

  • New Pediatric Labeling Information

9. APPENDIX 2: LIST OF DRUGS OBTAINING PEDIATRIC EXCLUSIVITY BY FDA

  • Pediatric Exclusivity Granted
  • August 2014

IV. COMPETITIVE LANDSCAPE

Back to Top